Compare · AMPX vs DHR
AMPX vs DHR
Side-by-side comparison of Amprius Technologies Inc. (AMPX) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- AMPX operates in Miscellaneous, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $157.95B, about 135.2x AMPX ($1.17B).
- Over the past year, AMPX is down 34.1% and DHR is up 9.8% - DHR leads by 43.9 points.
- DHR has been more active in the news (10 items in the past 4 weeks vs 5 for AMPX).
- DHR has more recent analyst coverage (25 ratings vs 10 for AMPX).
- Company
- Amprius Technologies Inc.
- Danaher Corporation
- Price
- $8.41+5.39%
- $231.45+2.99%
- Market cap
- $1.17B
- $157.95B
- 1M return
- -7.68%
- +11.06%
- 1Y return
- -34.14%
- +9.75%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- News (4w)
- 5
- 10
- Recent ratings
- 10
- 25
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest AMPX
- Canaccord Genuity initiated coverage on Amprius Technologies with a new price target
- SEC Form S-3ASR filed by Amprius Technologies Inc.
- CAMINUS Signs Contract Manufacturing Agreement with Amprius Technologies for U.S. Pouch Cell Production
- Amprius Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Amprius Secures $75 Million Grant for American High-Energy Density Battery Production
- Amprius Introduces SiCore®500 – High Energy Density Cells for Unmanned Aviation
- Amprius Sets September 2026 Events Schedule
- SEC Form 144 filed by Amprius Technologies Inc.
- Director Sun Kang sold $642,186 worth of shares (62,101 units at $10.34), decreasing direct ownership by 5% to 1,218,397 units (SEC Form 4) to satisfy tax liability
- Chief Technology Officer Stefan Constantin Ionel sold $306,931 worth of shares (29,681 units at $10.34), decreasing direct ownership by 4% to 771,629 units (SEC Form 4) (withholding obligation)
Latest DHR
- SEC Form 4 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- Danaher Collaborates with NVIDIA to Advance Autonomous Science
- SEC Form 8-K filed by Danaher Corporation
- Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
- Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
- New insider Moler Heathre T claimed ownership of 5,356 shares (SEC Form 3)
- New insider Muppaneni Shashanka claimed ownership of 5,901 shares (SEC Form 3)
- Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer
- Danaher Schedules Third Quarter 2026 Earnings Conference Call